Jane Wey

2.1k total citations
24 papers, 1.8k citations indexed

About

Jane Wey is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Jane Wey has authored 24 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Jane Wey's work include Angiogenesis and VEGF in Cancer (12 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Jane Wey is often cited by papers focused on Angiogenesis and VEGF in Cancer (12 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Jane Wey collaborates with scholars based in United States and United Kingdom. Jane Wey's co-authors include Lee M. Ellis, Marya F. McCarty, Oliver Stoeltzing, Fan Fan, Wenbiao Liu, Ray Somcio, Jonathan Lytton, Kwan‐Dun Wu, David Bungard and Daniel J. Hicklin and has published in prestigious journals such as Journal of Clinical Investigation, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Jane Wey

23 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Wey United States 15 1.2k 645 521 250 203 24 1.8k
Lin Pei United States 24 1.3k 1.1× 488 0.8× 478 0.9× 217 0.9× 202 1.0× 48 2.6k
Koichi Hamada Japan 21 1.7k 1.4× 536 0.8× 465 0.9× 221 0.9× 174 0.9× 56 2.8k
Douglas Armellino United States 15 1.3k 1.1× 738 1.1× 401 0.8× 123 0.5× 133 0.7× 18 2.3k
Bryan K. McCune United States 17 1.1k 0.9× 557 0.9× 253 0.5× 303 1.2× 96 0.5× 26 2.0k
David R. Emlet United States 16 1.3k 1.1× 598 0.9× 231 0.4× 216 0.9× 125 0.6× 24 2.1k
Cu Nguyen United States 15 2.0k 1.7× 541 0.8× 163 0.3× 379 1.5× 146 0.7× 24 2.5k
Sina Koch Germany 15 1.3k 1.1× 417 0.6× 288 0.6× 108 0.4× 189 0.9× 22 2.0k
Suya Yang United States 17 1.2k 1.0× 219 0.3× 329 0.6× 135 0.5× 80 0.4× 18 1.8k
Donna Hylton United States 8 1.2k 1.0× 544 0.8× 356 0.7× 176 0.7× 96 0.5× 12 2.3k
Landon J. Inge United States 21 1.1k 0.9× 433 0.7× 307 0.6× 242 1.0× 100 0.5× 41 1.7k

Countries citing papers authored by Jane Wey

Since Specialization
Citations

This map shows the geographic impact of Jane Wey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Wey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Wey more than expected).

Fields of papers citing papers by Jane Wey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Wey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Wey. The network helps show where Jane Wey may publish in the future.

Co-authorship network of co-authors of Jane Wey

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Wey. A scholar is included among the top collaborators of Jane Wey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Wey. Jane Wey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris‐Stiff, Gareth, et al.. (2020). Neoadjuvant chemoradiation is associated with decreased lymph node ratio in borderline resectable pancreatic cancer: A propensity score matched analysis. Hepatobiliary & pancreatic diseases international. 20(1). 74–79. 5 indexed citations
2.
Wey, Jane, et al.. (2019). Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer. Hepatobiliary & pancreatic diseases international. 18(4). 373–378. 12 indexed citations
3.
Colvin, Jennifer S., et al.. (2018). Utilization of Quality Improvement Methodology to Standardize Communication of Outside Hospital Transfers in a General Surgery Program. Journal of surgical education. 75(6). 1544–1550. 1 indexed citations
4.
Monteiro, Rosebel, Gareth Morris‐Stiff, Jane Wey, et al.. (2017). Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs. Journal of Gastrointestinal Surgery. 21(9). 1420–1427. 20 indexed citations
5.
Augustin, Toms, Matthew D. Burstein, Eric B. Schneider, et al.. (2016). Frailty predicts risk of life-threatening complications and mortality after pancreatic resections. Surgery. 160(4). 987–996. 79 indexed citations
6.
Takahashi, Hideo, Maitham A. Moslim, Naftali Presser, et al.. (2016). Absence of a Periampullary Mass on Cross-sectional Imaging Delays Diagnosis and Time to Pancreatoduodenectomy But Does Not Impair Outcome. Journal of Gastrointestinal Surgery. 20(6). 1179–1187.
7.
Chalikonda, Sricharan, et al.. (2016). Use of Postoperative Day 1 Drain Amylase Levels to Predict Postoperative Pancreatic Fistulas. Journal of the American College of Surgeons. 223(4). e147–e148. 2 indexed citations
8.
Sohal, Davendra, Shiva Shrotriya, Robert Pelley, et al.. (2015). Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study. Cancer. 121(11). 1779–1784. 26 indexed citations
9.
Eisenberg, David P., Jane Wey, Philip Bao, et al.. (2010). Short- and long-term costs of laparoscopic colectomy are significantly less than open colectomy. Surgical Endoscopy. 24(9). 2128–2134. 9 indexed citations
10.
McCarty, Marya F., Ray Somcio, Oliver Stoeltzing, et al.. (2007). Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. Journal of Clinical Investigation. 117(8). 2114–2122. 139 indexed citations
11.
Wey, Jane, Michael J. Gray, Fei Fan, et al.. (2005). Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. British Journal of Cancer. 93(2). 233–241. 103 indexed citations
12.
Liu, Wenbiao, Alexander A. Parikh, Oliver Stoeltzing, et al.. (2005). Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF. Cytokine. 32(5). 206–212. 38 indexed citations
13.
Wey, Jane, Fan Fan, Michael J. Gray, et al.. (2005). Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer. 104(2). 427–438. 160 indexed citations
14.
Fan, Fan, Jane Wey, Marya F. McCarty, et al.. (2005). Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene. 24(16). 2647–2653. 270 indexed citations
15.
Fan, Fan, Jane Wey, Anna Belcheva, et al.. (2004). Expression and function of vascular endothelial growth factor receptor–1 in human colon cancer cells. Cancer Research. 64. 1000–1000. 1 indexed citations
16.
Wey, Jane, Michael J. Gray, Fan Fan, et al.. (2004). Neuropilin-1, a novel vascular endothelial growth factor receptor, promotes chemoresistance in pancreatic cancer cell lines. Cancer Research. 64. 1127–1127. 1 indexed citations
17.
Stoeltzing, Oliver, Marya F. McCarty, Jane Wey, et al.. (2004). Role of Hypoxia-Inducible Factor 1  in Gastric Cancer Cell Growth, Angiogenesis, and Vessel Maturation. JNCI Journal of the National Cancer Institute. 96(12). 946–956. 202 indexed citations
18.
Wey, Jane, Oliver Stoeltzing, & Lee M. Ellis. (2004). Vascular endothelial growth factor receptors: expression and function in solid tumors.. PubMed. 2(1). 37–45. 42 indexed citations
19.
Bauer, Todd W., Marya F. McCarty, Jane Wey, et al.. (2004). Therapeutic targeting of the insulin-like growth factor-I receptor (IGF-IR) plus oxaliplatin decreases hepatic growth of human colon cancer. Annals of Surgical Oncology. 11(S2). S65–S65. 1 indexed citations
20.
Bourdon, Emmanuel, Dae‐Kyung Kang, Manik C. Ghosh, et al.. (2003). The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2. Blood Cells Molecules and Diseases. 31(2). 247–255. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Pei Breakdown of academic impact, for papers by Koichi Hamada Breakdown of academic impact, for papers by Douglas Armellino Breakdown of academic impact, for papers by Bryan K. McCune Breakdown of academic impact, for papers by David R. Emlet Breakdown of academic impact, for papers by Cu Nguyen Breakdown of academic impact, for papers by Sina Koch Breakdown of academic impact, for papers by Suya Yang Breakdown of academic impact, for papers by Donna Hylton Breakdown of academic impact, for papers by Landon J. Inge
Rankless by CCL
2026